Re-evaluation of anti-TNF use in a cohort of IBD patients in a non-academic hospital.
Withdrawn
- Conditions
- Inflammatory Bowel disease10017969
- Registration Number
- NL-OMON38980
- Lead Sponsor
- Martini Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
18 years or older
mentally compentent
diagnose of IBD
signed informed consent
well known history
Exclusion Criteria
pregnant women
existing treatment with MTX
history of fistels
second indication for anti TNF, such as Bechterew
serious co-morbidiy
unable to understand or write Dutch
serious transfusionreaction on infliximab or Humira in the past
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Which % of the studypopulation is succesfully changed into optimized thiopurine<br /><br>treatment? </p><br>
- Secondary Outcome Measures
Name Time Method <p>1. Which subgroups are present?<br /><br>2. Which % and which subgroups can be succesfully changed into a optimized<br /><br>thiopurine treatment. (with TNF treatment)<br /><br>3. Which % and which subgroup can stop the anti-TNF long term (> one year)?</p><br>